Global Pet Insurance Market By Animal Type (Dogs, Cats, Others); By Policy Type (Accident only pet insurance, Time Limited Pet Insurance, Maximum Benefit Pet Insurance, Lifetime Pet Insurance); By Coverage (Illnesses, Accidents, Hereditary Conditions, Congenital Conditions, Chronic Conditions, Cancer, Diagnostic Treatment, X-Rays, Blood Tests, Ultrasounds, Surgery, Hospitalization, Prescription Medications, Emergency Care, Specialty Care, Alternative Treatment, Others); By Sales Channel (Direct, Indirect); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global pet insurance market was valued at US$ 5.2 Bn in 2021, growing at an estimated CAGR of 14.9% over the forecast period. Insurance basically is a protection from any type of financial loss in return for a fee, a party agrees to assure another party compensation in case of any type of loss, damage, or even an injury. Insurance is a type of managing mainly used to hedge in opposition of the risk of a loss that is contingent or uncertain. Gone are the days when insurance was just limited to humans or things. Even pets are being insured in today’s time. People’s love for their pets is not hidden and the prices of certain breeds of cats, dogs and other animals are just unbelievable. Pet insurance happens to be a form of insurance where the insurance company pays, in part or completely, for veterinary treatment of the pet that was insured if he is ill or injured. In certain policies, the owner of pet is paid in case of the death of the pet or he is stolen or lost. The global pet insurance market is rampantly growing in wake of rising prices of veterinary medicine. The veterinary surgeons or doctors are extensively using medical techniques that involve costly drugs and medicines. Also the fact that the expectations regarding the health of the pet along with better standards of living as compared to last decade contributes to the growth of this market.
Animal Type Outlook
On the basis of animal type, the global pet insurance market has been divided into dogs, cats and others. Dog is definitely man's best friend and this is exactly why this segment accounts for maximum amount of revenue generated by this market. The mankind has been considering dogs as their family member since ages, and this applies when it comes to the medical treatment sought for them. Also, certain breeds of dogs like Tibetan Mastiff cost a fortune and this is why the owners are extra concerned about their health and safety. This is where insurance companies prove a great option for the pet owners.
Global Pet Insurance Market Revenue & Forecast, (US$ Million), 2022 – 2030
Policy Type Outlook
On the basis of policy type, the global pet insurance market has been categorised into accident only pet insurance, time limited pet insurance, maximum benefit pet insurance and lifetime pet insurance. Lifetime pet insurance safeguards the pet and its owners against any illness that is long-term or critical. Diseases like arthritis and eczema are those diseases covered in this type of insurance. Meanwhile, the time limited pet insurance provides monetary protection to the pet only for a certain period after the pet gets infected with any illness or is injured. On the other hand, the accident only pet insurance covers only cases where pet is injured or dead due to any type of accident.
Coverage Outlook
On the basis of coverage, the global pet insurance market has been divided into illnesses, accidents, hereditary conditions, congenital conditions, chronic conditions, cancer, diagnostic treatment, X-rays, blood tests, ultrasounds, surgery, hospitalization, prescription medications, emergency care, specialty care, alternative treatment and others. The number of new illnesses are rising continuously and not just humans, but pets too are at risk of getting infecting. This is exactly why the illnesses segment generates maximum amount of money for this market.
Sales Channel Outlook
The sales channel segment of the global pet insurance market has been bifurcated into direct and indirect. The direct segment dominates in terms of market share, as majority of lead insurance providers have their independent platforms like websites, social media pages and offices. This is where the customers can directly contact them. Rise of online markets also contributes to the growth of this market.
Region Outlook
On the basis of region, the global pet insurance market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of the Europe at present has been accounting for major chunk of revenue for this market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global pet insurance market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global pet insurance market are listed below:
- American Modern Insurance
- Figo Pet Insurance LLC
- GEICO
- Healthy Paws Pet Insurance, LLC
- Lemonade Insurance Agency, LLC
- MetLife Services and Solutions, LLC
- Pet Assure Corp.
- Pets Best Insurance Services, LLC
- Tata Capital Financial Services Limited
- The Travelers Indemnity Company
- TK PETCARE SOLUTIONS PRIVATE LIMITED
- Trupanion
- Other Market Participants
Global Pet Insurance Market
By Animal Type
- Dogs
- Cat
- Others
By Policy Type
- Accident only pet insurance
- Time limited pet insurance
- Maximum benefits pet insurance
- Lifetime pet insurance
By Coverage
- Illnesses
- Accidents
- Hereditary Conditions
- Congenital Conditions
- Chronic Conditions
- Cancer
- Diagnostic Treatment
- X-Rays, Blood Tests, Ultrasounds
- Surgery
- Hospitalization
- Prescription Medications
- Emergency Care
- Specialty Care
- Alternative Treatment
- Others
By Sales Channel
- Direct
- Indirect
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Pet Insurance Market
6.
Market
Synopsis:Â Pet Insurance Market
7.
Pet
Insurance Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Pet Insurance Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Pet Insurance Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Pet Insurance Market
7.8. PESTEL Analysis
8.
Global
Pet Insurance Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Pet Insurance Market Revenue (US$ Mn)
8.2. Global Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
8.2.1. Dogs Â
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 -
2021
8.2.1.3. Market Forecast, 2022 – 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2. Cats
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 -
2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 – 2030
8.2.3. Others
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 -
2021
8.2.3.3. Market Forecast, 2022 – 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market Estimation, 2015 - 2021
8.2.3.5.1.2. Market Forecast, 2022 – 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2021
8.2.3.5.2.2. Market Forecast, 2022 – 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2021
8.2.3.5.3.2. Market Forecast, 2022 – 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2021
8.2.3.5.4.2. Market Forecast, 2022 – 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market Estimation, 2015 - 2021
8.2.3.5.5.2. Market Forecast, 2022 – 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Animal Type
9.
Global
Pet Insurance Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
9.2.1. Accident only pet insurance
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 -
2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Time limited pet insurance
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 -
2021
9.2.2.3. Market Forecast, 2022 – 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.2.3. Maximum benefit pet insurance
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 -
2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 – 2030
9.2.4. Lifetime pet insurance
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 -
2021
9.2.4.3. Market Forecast, 2022 – 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 – 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 – 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 – 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 – 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Policy Type
10. Global Pet Insurance Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
10.2.1. Illnesses
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 -
2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Accidents
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 -
2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.2.3. Hereditary Conditions
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 -
2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 – 2030
10.2.4. Congenital Conditions
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 -
2021
10.2.4.3. Market Forecast, 2022 – 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 – 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 – 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 – 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 – 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 – 2030
10.2.5. Chronic Conditions
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 -
2021
10.2.5.3. Market Forecast, 2022 – 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 – 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 – 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 – 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 – 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 – 2030
10.2.6. Cancer
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 -
2021
10.2.6.3. Market Forecast, 2022 – 2030
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market Estimation, 2015 - 2021
10.2.6.5.1.2. Market Forecast, 2022 – 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market Estimation, 2015 - 2021
10.2.6.5.2.2. Market Forecast, 2022 – 2030
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market Estimation, 2015 - 2021
10.2.6.5.3.2. Market Forecast, 2022 – 2030
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market Estimation, 2015 - 2021
10.2.6.5.4.2. Market Forecast, 2022 – 2030
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market Estimation, 2015 - 2021
10.2.6.5.5.2. Market Forecast, 2022 – 2030
10.2.7. Diagnostic Treatment
10.2.7.1. Definition
10.2.7.2. Market Estimation and Penetration, 2015 -
2021
10.2.7.3. Market Forecast, 2022 – 2030
10.2.7.4. Compound Annual Growth Rate (CAGR)
10.2.7.5. Regional Bifurcation
10.2.7.5.1. North America
10.2.7.5.1.1. Market Estimation, 2015 - 2021
10.2.7.5.1.2. Market Forecast, 2022 – 2030
10.2.7.5.2. Europe
10.2.7.5.2.1. Market Estimation, 2015 - 2021
10.2.7.5.2.2. Market Forecast, 2022 – 2030
10.2.7.5.3. Asia Pacific
10.2.7.5.3.1. Market Estimation, 2015 - 2021
10.2.7.5.3.2. Market Forecast, 2022 – 2030
10.2.7.5.4. Middle East and Africa
10.2.7.5.4.1. Market Estimation, 2015 - 2021
10.2.7.5.4.2. Market Forecast, 2022 – 2030
10.2.7.5.5. Latin America
10.2.7.5.5.1. Market Estimation, 2015 - 2021
10.2.7.5.5.2. Market Forecast, 2022 – 2030
10.2.8. Â X-Rays, Blood Tests, Ultrasounds
10.2.8.1. Definition
10.2.8.2. Market Estimation and Penetration, 2015 -
2021
10.2.8.3. Market Forecast, 2022 – 2030
10.2.8.4. Compound Annual Growth Rate (CAGR)
10.2.8.5. Regional Bifurcation
10.2.8.5.1. North America
10.2.8.5.1.1. Market Estimation, 2015 - 2021
10.2.8.5.1.2. Market Forecast, 2022 – 2030
10.2.8.5.2. Europe
10.2.8.5.2.1. Market Estimation, 2015 - 2021
10.2.8.5.2.2. Market Forecast, 2022 – 2030
10.2.8.5.3. Asia Pacific
10.2.8.5.3.1. Market Estimation, 2015 - 2021
10.2.8.5.3.2. Market Forecast, 2022 – 2030
10.2.8.5.4. Middle East and Africa
10.2.8.5.4.1. Market Estimation, 2015 - 2021
10.2.8.5.4.2. Market Forecast, 2022 – 2030
10.2.8.5.5. Latin America
10.2.8.5.5.1. Market Estimation, 2015 - 2021
10.2.8.5.5.2. Market Forecast, 2022 – 2030
10.2.9. Surgery
10.2.9.1. Definition
10.2.9.2. Market Estimation and Penetration, 2015 -
2021
10.2.9.3. Market Forecast, 2022 – 2030
10.2.9.4. Compound Annual Growth Rate (CAGR)
10.2.9.5. Regional Bifurcation
10.2.9.5.1. North America
10.2.9.5.1.1. Market Estimation, 2015 - 2021
10.2.9.5.1.2. Market Forecast, 2022 – 2030
10.2.9.5.2. Europe
10.2.9.5.2.1. Market Estimation, 2015 - 2021
10.2.9.5.2.2. Market Forecast, 2022 – 2030
10.2.9.5.3. Asia Pacific
10.2.9.5.3.1. Market Estimation, 2015 - 2021
10.2.9.5.3.2. Market Forecast, 2022 – 2030
10.2.9.5.4. Middle East and Africa
10.2.9.5.4.1. Market Estimation, 2015 - 2021
10.2.9.5.4.2. Market Forecast, 2022 – 2030
10.2.9.5.5. Latin America
10.2.9.5.5.1. Market Estimation, 2015 - 2021
10.2.9.5.5.2. Market Forecast, 2022 – 2030
10.2.10. Hospitalization
10.2.10.1. Definition
10.2.10.2. Market Estimation and Penetration, 2015 -
2021
10.2.10.3. Market Forecast, 2022 – 2030
10.2.10.4. Compound Annual Growth Rate (CAGR)
10.2.10.5. Regional Bifurcation
10.2.10.5.1. North America
10.2.10.5.1.1. Market Estimation, 2015 - 2021
10.2.10.5.1.2. Market Forecast, 2022 – 2030
10.2.10.5.2. Europe
10.2.10.5.2.1. Market Estimation, 2015 - 2021
10.2.10.5.2.2. Market Forecast, 2022 – 2030
10.2.10.5.3. Asia Pacific
10.2.10.5.3.1. Market Estimation, 2015 - 2021
10.2.10.5.3.2. Market Forecast, 2022 – 2030
10.2.10.5.4. Middle East and Africa
10.2.10.5.4.1. Market Estimation, 2015 - 2021
10.2.10.5.4.2. Market Forecast, 2022 – 2030
10.2.10.5.5. Latin America
10.2.10.5.5.1. Market Estimation, 2015 - 2021
10.2.10.5.5.2. Market Forecast, 2022 – 2030
10.2.11. Prescription Medications
10.2.11.1. Definition
10.2.11.2. Market Estimation and Penetration, 2015 -
2021
10.2.11.3. Market Forecast, 2022 – 2030
10.2.11.4. Compound Annual Growth Rate (CAGR)
10.2.11.5. Regional Bifurcation
10.2.11.5.1. North America
10.2.11.5.1.1. Market Estimation, 2015 - 2021
10.2.11.5.1.2. Market Forecast, 2022 – 2030
10.2.11.5.2. Europe
10.2.11.5.2.1. Market Estimation, 2015 - 2021
10.2.11.5.2.2. Market Forecast, 2022 – 2030
10.2.11.5.3. Asia Pacific
10.2.11.5.3.1. Market Estimation, 2015 - 2021
10.2.11.5.3.2. Market Forecast, 2022 – 2030
10.2.11.5.4. Middle East and Africa
10.2.11.5.4.1. Market Estimation, 2015 - 2021
10.2.11.5.4.2. Market Forecast, 2022 – 2030
10.2.11.5.5. Latin America
10.2.11.5.5.1. Market Estimation, 2015 - 2021
10.2.11.5.5.2. Market Forecast, 2022 – 2030
10.2.12. Emergency Care
10.2.12.1. Definition
10.2.12.2. Market Estimation and Penetration, 2015 -
2021
10.2.12.3. Market Forecast, 2022 – 2030
10.2.12.4. Compound Annual Growth Rate (CAGR)
10.2.12.5. Regional Bifurcation
10.2.12.5.1. North America
10.2.12.5.1.1. Market Estimation, 2015 - 2021
10.2.12.5.1.2. Market Forecast, 2022 – 2030
10.2.12.5.2. Europe
10.2.12.5.2.1. Market Estimation, 2015 - 2021
10.2.12.5.2.2. Market Forecast, 2022 – 2030
10.2.12.5.3. Asia Pacific
10.2.12.5.3.1. Market Estimation, 2015 - 2021
10.2.12.5.3.2. Market Forecast, 2022 – 2030
10.2.12.5.4. Middle East and Africa
10.2.12.5.4.1. Market Estimation, 2015 - 2021
10.2.12.5.4.2. Market Forecast, 2022 – 2030
10.2.12.5.5. Latin America
10.2.12.5.5.1. Market Estimation, 2015 - 2021
10.2.12.5.5.2. Market Forecast, 2022 – 2030
10.2.13. Specialty Care
10.2.13.1. Definition
10.2.13.2. Market Estimation and Penetration, 2015 -
2021
10.2.13.3. Market Forecast, 2022 – 2030
10.2.13.4. Compound Annual Growth Rate (CAGR)
10.2.13.5. Regional Bifurcation
10.2.13.5.1. North America
10.2.13.5.1.1. Market Estimation, 2015 - 2021
10.2.13.5.1.2. Market Forecast, 2022 – 2030
10.2.13.5.2. Europe
10.2.13.5.2.1. Market Estimation, 2015 - 2021
10.2.13.5.2.2. Market Forecast, 2022 – 2030
10.2.13.5.3. Asia Pacific
10.2.13.5.3.1. Market Estimation, 2015 - 2021
10.2.13.5.3.2. Market Forecast, 2022 – 2030
10.2.13.5.4. Middle East and Africa
10.2.13.5.4.1. Market Estimation, 2015 - 2021
10.2.13.5.4.2. Market Forecast, 2022 – 2030
10.2.13.5.5. Latin America
10.2.13.5.5.1. Market Estimation, 2015 - 2021
10.2.13.5.5.2. Market Forecast, 2022 – 2030
10.2.14. Alternative Treatment
10.2.14.1. Definition
10.2.14.2. Market Estimation and Penetration, 2015 -
2021
10.2.14.3. Market Forecast, 2022 – 2030
10.2.14.4. Compound Annual Growth Rate (CAGR)
10.2.14.5. Regional Bifurcation
10.2.14.5.1. North America
10.2.14.5.1.1. Market Estimation, 2015 - 2021
10.2.14.5.1.2. Market Forecast, 2022 – 2030
10.2.14.5.2. Europe
10.2.14.5.2.1. Market Estimation, 2015 - 2021
10.2.14.5.2.2. Market Forecast, 2022 – 2030
10.2.14.5.3. Asia Pacific
10.2.14.5.3.1. Market Estimation, 2015 - 2021
10.2.14.5.3.2. Market Forecast, 2022 – 2030
10.2.14.5.4. Middle East and Africa
10.2.14.5.4.1. Market Estimation, 2015 - 2021
10.2.14.5.4.2. Market Forecast, 2022 – 2030
10.2.14.5.5. Latin America
10.2.14.5.5.1. Market Estimation, 2015 - 2021
10.2.14.5.5.2. Market Forecast, 2022 – 2030
10.2.15. Others
10.2.15.1. Definition
10.2.15.2. Market Estimation and Penetration, 2015 -
2021
10.2.15.3. Market Forecast, 2022 – 2030
10.2.15.4. Compound Annual Growth Rate (CAGR)
10.2.15.5. Regional Bifurcation
10.2.15.5.1. North America
10.2.15.5.1.1. Market Estimation, 2015 - 2021
10.2.15.5.1.2. Market Forecast, 2022 – 2030
10.2.15.5.2. Europe
10.2.15.5.2.1. Market Estimation, 2015 - 2021
10.2.15.5.2.2. Market Forecast, 2022 – 2030
10.2.15.5.3. Asia Pacific
10.2.15.5.3.1. Market Estimation, 2015 - 2021
10.2.15.5.3.2. Market Forecast, 2022 – 2030
10.2.15.5.4. Middle East and Africa
10.2.15.5.4.1. Market Estimation, 2015 - 2021
10.2.15.5.4.2. Market Forecast, 2022 – 2030
10.2.15.5.5. Latin America
10.2.15.5.5.1. Market Estimation, 2015 - 2021
10.2.15.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Coverage
11. Global Pet Insurance Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
11.2.1. Direct
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 -
2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Indirect
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 -
2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By Sales Channel
12. North America Pet Insurance Market Analysis
and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America Pet Insurance Market Revenue
(US$ Mn)
12.2. North America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
12.2.1. Dogs Â
12.2.2. Cats
12.2.3. Others
12.3. North America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
12.3.1. Accident only pet insurance
12.3.2. Time limited pet insurance
12.3.3. Maximum benefit pet insurance
12.3.4. Lifetime pet insurance
12.4. North America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
12.4.1. Illnesses
12.4.2. Accidents
12.4.3. Hereditary Conditions
12.4.4. Congenital Conditions
12.4.5. Chronic Conditions
12.4.6. Cancer
12.4.7. Diagnostic Treatment
12.4.8. Â X-Rays, Blood Tests, Ultrasounds
12.4.9. Surgery
12.4.10. Hospitalization
12.4.11. Prescription Medications
12.4.12. Emergency Care
12.4.13. Specialty Care
12.4.14. Alternative Treatment
12.4.15. Others
12.5. North America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
12.5.1. Direct
12.5.2. Indirect
12.6. North America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Pet Insurance Market Revenue (US$ Mn) and
Forecasts, By Animal Type
12.6.1.1.1. Dogs Â
12.6.1.1.2. Cats
12.6.1.1.3. Others
12.6.1.2. U.S Pet Insurance Market Revenue (US$ Mn) and
Forecasts, By Policy Type
12.6.1.2.1. Accident only pet insurance
12.6.1.2.2. Time limited pet insurance
12.6.1.2.3. Maximum benefit pet insurance
12.6.1.2.4. Lifetime pet insurance
12.6.1.3. U.S Pet Insurance Market Revenue (US$ Mn) and
Forecasts, By Coverage
12.6.1.3.1. Illnesses
12.6.1.3.2. Accidents
12.6.1.3.3. Hereditary Conditions
12.6.1.3.4. Congenital Conditions
12.6.1.3.5. Chronic Conditions
12.6.1.3.6. Cancer
12.6.1.3.7. Diagnostic Treatment
12.6.1.3.8. Â X-Rays, Blood Tests, Ultrasounds
12.6.1.3.9. Surgery
12.6.1.3.10. Hospitalization
12.6.1.3.11. Prescription Medications
12.6.1.3.12. Emergency Care
12.6.1.3.13. Specialty Care
12.6.1.3.14. Alternative Treatment
12.6.1.3.15. Others
12.6.1.4. U.S Pet Insurance Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
12.6.1.4.1. Direct
12.6.1.4.2. Indirect
12.6.2. Canada
12.6.2.1. Canada Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
12.6.2.1.1. Dogs Â
12.6.2.1.2. Cats
12.6.2.1.3. Others
12.6.2.2. Canada Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
12.6.2.2.1. Accident only pet insurance
12.6.2.2.2. Time limited pet insurance
12.6.2.2.3. Maximum benefit pet insurance
12.6.2.2.4. Lifetime pet insurance
12.6.2.3. Canada Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
12.6.2.3.1. Illnesses
12.6.2.3.2. Accidents
12.6.2.3.3. Hereditary Conditions
12.6.2.3.4. Congenital Conditions
12.6.2.3.5. Chronic Conditions
12.6.2.3.6. Cancer
12.6.2.3.7. Diagnostic Treatment
12.6.2.3.8. Â X-Rays, Blood Tests, Ultrasounds
12.6.2.3.9. Surgery
12.6.2.3.10. Hospitalization
12.6.2.3.11. Prescription Medications
12.6.2.3.12. Emergency Care
12.6.2.3.13. Specialty Care
12.6.2.3.14. Alternative Treatment
12.6.2.3.15. Others
12.6.2.4. Canada Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
12.6.2.4.1. Direct
12.6.2.4.2. Indirect
12.6.3. Mexico
12.6.3.1. Mexico Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
12.6.3.1.1. Dogs Â
12.6.3.1.2. Cats
12.6.3.1.3. Others
12.6.3.2. Mexico Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
12.6.3.2.1. Accident only pet insurance
12.6.3.2.2. Time limited pet insurance
12.6.3.2.3. Maximum benefit pet insurance
12.6.3.2.4. Lifetime pet insurance
12.6.3.3. Mexico Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
12.6.3.3.1. Illnesses
12.6.3.3.2. Accidents
12.6.3.3.3. Hereditary Conditions
12.6.3.3.4. Congenital Conditions
12.6.3.3.5. Chronic Conditions
12.6.3.3.6. Cancer
12.6.3.3.7. Diagnostic Treatment
12.6.3.3.8. Â X-Rays, Blood Tests, Ultrasounds
12.6.3.3.9. Surgery
12.6.3.3.10. Hospitalization
12.6.3.3.11. Prescription Medications
12.6.3.3.12. Emergency Care
12.6.3.3.13. Specialty Care
12.6.3.3.14. Alternative Treatment
12.6.3.3.15. Others
12.6.3.4. Mexico Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
12.6.3.4.1. Direct
12.6.3.4.2. Indirect
12.6.4. Rest of North America
12.6.4.1. Rest of North America Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Animal Type
12.6.4.1.1. Dogs Â
12.6.4.1.2. Cats
12.6.4.1.3. Others
12.6.4.2. Rest of North America Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Policy Type
12.6.4.2.1. Accident only pet insurance
12.6.4.2.2. Time limited pet insurance
12.6.4.2.3. Maximum benefit pet insurance
12.6.4.2.4. Lifetime pet insurance
12.6.4.3. Rest of North America Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Coverage
12.6.4.3.1. Illnesses
12.6.4.3.2. Accidents
12.6.4.3.3. Hereditary Conditions
12.6.4.3.4. Congenital Conditions
12.6.4.3.5. Chronic Conditions
12.6.4.3.6. Cancer
12.6.4.3.7. Diagnostic Treatment
12.6.4.3.8. Â X-Rays, Blood Tests, Ultrasounds
12.6.4.3.9. Surgery
12.6.4.3.10. Hospitalization
12.6.4.3.11. Prescription Medications
12.6.4.3.12. Emergency Care
12.6.4.3.13. Specialty Care
12.6.4.3.14. Alternative Treatment
12.6.4.3.15. Others
12.6.4.4. Rest of North America Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
12.6.4.4.1. Direct
12.6.4.4.2. Indirect
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Animal Type
12.7.3. By Policy Type
12.7.4. By Coverage
12.7.5. By Sales Channel
13. Europe Pet Insurance Market Analysis and
Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe Pet Insurance Market Revenue (US$ Mn)
13.2. Europe Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.2.1. Dogs Â
13.2.2. Cats
13.2.3. Others
13.3. Europe Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
13.3.1. Accident only pet insurance
13.3.2. Time limited pet insurance
13.3.3. Maximum benefit pet insurance
13.3.4. Lifetime pet insurance
13.4. Europe Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
13.4.1. Illnesses
13.4.2. Accidents
13.4.3. Hereditary Conditions
13.4.4. Congenital Conditions
13.4.5. Chronic Conditions
13.4.6. Cancer
13.4.7. Diagnostic Treatment
13.4.8. Â X-Rays, Blood Tests, Ultrasounds
13.4.9. Surgery
13.4.10. Hospitalization
13.4.11. Prescription Medications
13.4.12. Emergency Care
13.4.13. Specialty Care
13.4.14. Alternative Treatment
13.4.15. Others
13.5. Europe Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
13.5.1. Direct
13.5.2. Indirect
13.6. Europe Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.1. France
13.6.1.1. France Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.6.1.1.1. Dogs Â
13.6.1.1.2. Cats
13.6.1.1.3. Others
13.6.1.2. France Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
13.6.1.2.1. Accident only pet insurance
13.6.1.2.2. Time limited pet insurance
13.6.1.2.3. Maximum benefit pet insurance
13.6.1.2.4. Lifetime pet insurance
13.6.1.3. France Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
13.6.1.3.1. Illnesses
13.6.1.3.2. Accidents
13.6.1.3.3. Hereditary Conditions
13.6.1.3.4. Congenital Conditions
13.6.1.3.5. Chronic Conditions
13.6.1.3.6. Cancer
13.6.1.3.7. Diagnostic Treatment
13.6.1.3.8. Â X-Rays, Blood Tests, Ultrasounds
13.6.1.3.9. Surgery
13.6.1.3.10. Hospitalization
13.6.1.3.11. Prescription Medications
13.6.1.3.12. Emergency Care
13.6.1.3.13. Specialty Care
13.6.1.3.14. Alternative Treatment
13.6.1.3.15. Others
13.6.1.4. France Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
13.6.1.4.1. Direct
13.6.1.4.2. Indirect
13.6.2. The UK
13.6.2.1. The UK Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.6.2.1.1. Dogs Â
13.6.2.1.2. Cats
13.6.2.1.3. Others
13.6.2.2. The UK Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
13.6.2.2.1. Accident only pet insurance
13.6.2.2.2. Time limited pet insurance
13.6.2.2.3. Maximum benefit pet insurance
13.6.2.2.4. Lifetime pet insurance
13.6.2.3. The UK Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
13.6.2.3.1. Illnesses
13.6.2.3.2. Accidents
13.6.2.3.3. Hereditary Conditions
13.6.2.3.4. Congenital Conditions
13.6.2.3.5. Chronic Conditions
13.6.2.3.6. Cancer
13.6.2.3.7. Diagnostic Treatment
13.6.2.3.8. Â X-Rays, Blood Tests, Ultrasounds
13.6.2.3.9. Surgery
13.6.2.3.10. Hospitalization
13.6.2.3.11. Prescription Medications
13.6.2.3.12. Emergency Care
13.6.2.3.13. Specialty Care
13.6.2.3.14. Alternative Treatment
13.6.2.3.15. Others
13.6.2.4. The UK Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
13.6.2.4.1. Direct
13.6.2.4.2. Indirect
13.6.3. Spain
13.6.3.1. Spain Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.6.3.1.1. Dogs Â
13.6.3.1.2. Cats
13.6.3.1.3. Others
13.6.3.2. Spain Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
13.6.3.2.1. Accident only pet insurance
13.6.3.2.2. Time limited pet insurance
13.6.3.2.3. Maximum benefit pet insurance
13.6.3.2.4. Lifetime pet insurance
13.6.3.3. Spain Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
13.6.3.3.1. Illnesses
13.6.3.3.2. Accidents
13.6.3.3.3. Hereditary Conditions
13.6.3.3.4. Congenital Conditions
13.6.3.3.5. Chronic Conditions
13.6.3.3.6. Cancer
13.6.3.3.7. Diagnostic Treatment
13.6.3.3.8. Â X-Rays, Blood Tests, Ultrasounds
13.6.3.3.9. Surgery
13.6.3.3.10. Hospitalization
13.6.3.3.11. Prescription Medications
13.6.3.3.12. Emergency Care
13.6.3.3.13. Specialty Care
13.6.3.3.14. Alternative Treatment
13.6.3.3.15. Others
13.6.3.4. Spain Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
13.6.3.4.1. Direct
13.6.3.4.2. Indirect
13.6.4. Germany
13.6.4.1. Germany Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.6.4.1.1. Dogs Â
13.6.4.1.2. Cats
13.6.4.1.3. Others
13.6.4.2. Germany Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
13.6.4.2.1. Accident only pet insurance
13.6.4.2.2. Time limited pet insurance
13.6.4.2.3. Maximum benefit pet insurance
13.6.4.2.4. Lifetime pet insurance
13.6.4.3. Germany Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
13.6.4.3.1. Illnesses
13.6.4.3.2. Accidents
13.6.4.3.3. Hereditary Conditions
13.6.4.3.4. Congenital Conditions
13.6.4.3.5. Chronic Conditions
13.6.4.3.6. Cancer
13.6.4.3.7. Diagnostic Treatment
13.6.4.3.8. Â X-Rays, Blood Tests, Ultrasounds
13.6.4.3.9. Surgery
13.6.4.3.10. Hospitalization
13.6.4.3.11. Prescription Medications
13.6.4.3.12. Emergency Care
13.6.4.3.13. Specialty Care
13.6.4.3.14. Alternative Treatment
13.6.4.3.15. Others
13.6.4.4. Germany Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
13.6.4.4.1. Direct
13.6.4.4.2. Indirect
13.6.5. Italy
13.6.5.1. Italy Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.6.5.1.1. Dogs Â
13.6.5.1.2. Cats
13.6.5.1.3. Others
13.6.5.2. Italy Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
13.6.5.2.1. Accident only pet insurance
13.6.5.2.2. Time limited pet insurance
13.6.5.2.3. Maximum benefit pet insurance
13.6.5.2.4. Lifetime pet insurance
13.6.5.3. Italy Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
13.6.5.3.1. Illnesses
13.6.5.3.2. Accidents
13.6.5.3.3. Hereditary Conditions
13.6.5.3.4. Congenital Conditions
13.6.5.3.5. Chronic Conditions
13.6.5.3.6. Cancer
13.6.5.3.7. Diagnostic Treatment
13.6.5.3.8. Â X-Rays, Blood Tests, Ultrasounds
13.6.5.3.9. Surgery
13.6.5.3.10. Hospitalization
13.6.5.3.11. Prescription Medications
13.6.5.3.12. Emergency Care
13.6.5.3.13. Specialty Care
13.6.5.3.14. Alternative Treatment
13.6.5.3.15. Others
13.6.5.4. Italy Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
13.6.5.4.1. Direct
13.6.5.4.2. Indirect
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
13.6.6.1.1. Dogs Â
13.6.6.1.2. Cats
13.6.6.1.3. Others
13.6.6.2. Nordic Countries Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
13.6.6.2.1. Accident only pet insurance
13.6.6.2.2. Time limited pet insurance
13.6.6.2.3. Maximum benefit pet insurance
13.6.6.2.4. Lifetime pet insurance
13.6.6.3. Nordic Countries Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
13.6.6.3.1. Illnesses
13.6.6.3.2. Accidents
13.6.6.3.3. Hereditary Conditions
13.6.6.3.4. Congenital Conditions
13.6.6.3.5. Chronic Conditions
13.6.6.3.6. Cancer
13.6.6.3.7. Diagnostic Treatment
13.6.6.3.8. Â X-Rays, Blood Tests, Ultrasounds
13.6.6.3.9. Surgery
13.6.6.3.10. Hospitalization
13.6.6.3.11. Prescription Medications
13.6.6.3.12. Emergency Care
13.6.6.3.13. Specialty Care
13.6.6.3.14. Alternative Treatment
13.6.6.3.15. Others
13.6.6.4. Nordic Countries Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
13.6.6.4.1. Direct
13.6.6.4.2. Indirect
13.6.6.5. Nordic Countries Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
13.6.7.1.1. Dogs Â
13.6.7.1.2. Cats
13.6.7.1.3. Others
13.6.7.2. Benelux Union Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
13.6.7.2.1. Accident only pet insurance
13.6.7.2.2. Time limited pet insurance
13.6.7.2.3. Maximum benefit pet insurance
13.6.7.2.4. Lifetime pet insurance
13.6.7.3. Benelux Union Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
13.6.7.3.1. Illnesses
13.6.7.3.2. Accidents
13.6.7.3.3. Hereditary Conditions
13.6.7.3.4. Congenital Conditions
13.6.7.3.5. Chronic Conditions
13.6.7.3.6. Cancer
13.6.7.3.7. Diagnostic Treatment
13.6.7.3.8. Â X-Rays, Blood Tests, Ultrasounds
13.6.7.3.9. Surgery
13.6.7.3.10. Hospitalization
13.6.7.3.11. Prescription Medications
13.6.7.3.12. Emergency Care
13.6.7.3.13. Specialty Care
13.6.7.3.14. Alternative Treatment
13.6.7.3.15. Others
13.6.7.4. Benelux Union Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
13.6.7.4.1. Direct
13.6.7.4.2. Indirect
13.6.7.5. Benelux Union Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
13.6.8.1.1. Dogs Â
13.6.8.1.2. Cats
13.6.8.1.3. Others
13.6.8.2. Rest of Europe Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
13.6.8.2.1. Accident only pet insurance
13.6.8.2.2. Time limited pet insurance
13.6.8.2.3. Maximum benefit pet insurance
13.6.8.2.4. Lifetime pet insurance
13.6.8.3. Rest of Europe Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
13.6.8.3.1. Illnesses
13.6.8.3.2. Accidents
13.6.8.3.3. Hereditary Conditions
13.6.8.3.4. Congenital Conditions
13.6.8.3.5. Chronic Conditions
13.6.8.3.6. Cancer
13.6.8.3.7. Diagnostic Treatment
13.6.8.3.8. Â X-Rays, Blood Tests, Ultrasounds
13.6.8.3.9. Surgery
13.6.8.3.10. Hospitalization
13.6.8.3.11. Prescription Medications
13.6.8.3.12. Emergency Care
13.6.8.3.13. Specialty Care
13.6.8.3.14. Alternative Treatment
13.6.8.3.15. Others
13.6.8.4. Rest of Europe Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
13.6.8.4.1. Direct
13.6.8.4.2. Indirect
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Animal Type
13.7.3. By Policy Type
13.7.4. By Coverage
13.7.5. By Sales Channel
14. Asia Pacific Pet Insurance Market Analysis
and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia Pacific Pet Insurance Market Revenue
(US$ Mn)
14.2. Asia Pacific Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
14.2.1. Dogs Â
14.2.2. Cats
14.2.3. Others
14.3. Asia Pacific Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
14.3.1. Accident only pet insurance
14.3.2. Time limited pet insurance
14.3.3. Maximum benefit pet insurance
14.3.4. Lifetime pet insurance
14.4. Asia Pacific Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
14.4.1. Illnesses
14.4.2. Accidents
14.4.3. Hereditary Conditions
14.4.4. Congenital Conditions
14.4.5. Chronic Conditions
14.4.6. Cancer
14.4.7. Diagnostic Treatment
14.4.8. Â X-Rays, Blood Tests, Ultrasounds
14.4.9. Surgery
14.4.10. Hospitalization
14.4.11. Prescription Medications
14.4.12. Emergency Care
14.4.13. Specialty Care
14.4.14. Alternative Treatment
14.4.15. Others
14.5. Asia Pacific Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
14.5.1. Direct
14.5.2. Indirect
14.6. Asia Pacific Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
14.6.1.1.1. Dogs Â
14.6.1.1.2. Cats
14.6.1.1.3. Others
14.6.1.2. China Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
14.6.1.2.1. Accident only pet insurance
14.6.1.2.2. Time limited pet insurance
14.6.1.2.3. Maximum benefit pet insurance
14.6.1.2.4. Lifetime pet insurance
14.6.1.3. China Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
14.6.1.3.1. Illnesses
14.6.1.3.2. Accidents
14.6.1.3.3. Hereditary Conditions
14.6.1.3.4. Congenital Conditions
14.6.1.3.5. Chronic Conditions
14.6.1.3.6. Cancer
14.6.1.3.7. Diagnostic Treatment
14.6.1.3.8. Â X-Rays, Blood Tests, Ultrasounds
14.6.1.3.9. Surgery
14.6.1.3.10. Hospitalization
14.6.1.3.11. Prescription Medications
14.6.1.3.12. Emergency Care
14.6.1.3.13. Specialty Care
14.6.1.3.14. Alternative Treatment
14.6.1.3.15. Others
14.6.1.4. China Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.6.1.4.1. Direct
14.6.1.4.2. Indirect
14.6.2. Japan
14.6.2.1. Japan Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
14.6.2.1.1. Dogs Â
14.6.2.1.2. Cats
14.6.2.1.3. Others
14.6.2.2. Japan Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
14.6.2.2.1. Accident only pet insurance
14.6.2.2.2. Time limited pet insurance
14.6.2.2.3. Maximum benefit pet insurance
14.6.2.2.4. Lifetime pet insurance
14.6.2.3. Japan Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
14.6.2.3.1. Illnesses
14.6.2.3.2. Accidents
14.6.2.3.3. Hereditary Conditions
14.6.2.3.4. Congenital Conditions
14.6.2.3.5. Chronic Conditions
14.6.2.3.6. Cancer
14.6.2.3.7. Diagnostic Treatment
14.6.2.3.8. Â X-Rays, Blood Tests, Ultrasounds
14.6.2.3.9. Surgery
14.6.2.3.10. Hospitalization
14.6.2.3.11. Prescription Medications
14.6.2.3.12. Emergency Care
14.6.2.3.13. Specialty Care
14.6.2.3.14. Alternative Treatment
14.6.2.3.15. Others
14.6.2.4. Japan Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.6.2.4.1. Direct
14.6.2.4.2. Indirect
14.6.3. India
14.6.3.1. India Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
14.6.3.1.1. Dogs Â
14.6.3.1.2. Cats
14.6.3.1.3. Others
14.6.3.2. India Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
14.6.3.2.1. Accident only pet insurance
14.6.3.2.2. Time limited pet insurance
14.6.3.2.3. Maximum benefit pet insurance
14.6.3.2.4. Lifetime pet insurance
14.6.3.3. India Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
14.6.3.3.1. Illnesses
14.6.3.3.2. Accidents
14.6.3.3.3. Hereditary Conditions
14.6.3.3.4. Congenital Conditions
14.6.3.3.5. Chronic Conditions
14.6.3.3.6. Cancer
14.6.3.3.7. Diagnostic Treatment
14.6.3.3.8. Â X-Rays, Blood Tests, Ultrasounds
14.6.3.3.9. Surgery
14.6.3.3.10. Hospitalization
14.6.3.3.11. Prescription Medications
14.6.3.3.12. Emergency Care
14.6.3.3.13. Specialty Care
14.6.3.3.14. Alternative Treatment
14.6.3.3.15. Others
14.6.3.4. India Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.6.3.4.1. Direct
14.6.3.4.2. Indirect
14.6.4. New Zealand
14.6.4.1. New Zealand Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Animal Type
14.6.4.1.1. Dogs Â
14.6.4.1.2. Cats
14.6.4.1.3. Others
14.6.4.2. New Zealand Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Policy Type
14.6.4.2.1. Accident only pet insurance
14.6.4.2.2. Time limited pet insurance
14.6.4.2.3. Maximum benefit pet insurance
14.6.4.2.4. Lifetime pet insurance
14.6.4.3. New Zealand Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Coverage
14.6.4.3.1. Illnesses
14.6.4.3.2. Accidents
14.6.4.3.3. Hereditary Conditions
14.6.4.3.4. Congenital Conditions
14.6.4.3.5. Chronic Conditions
14.6.4.3.6. Cancer
14.6.4.3.7. Diagnostic Treatment
14.6.4.3.8. Â X-Rays, Blood Tests, Ultrasounds
14.6.4.3.9. Surgery
14.6.4.3.10. Hospitalization
14.6.4.3.11. Prescription Medications
14.6.4.3.12. Emergency Care
14.6.4.3.13. Specialty Care
14.6.4.3.14. Alternative Treatment
14.6.4.3.15. Others
14.6.4.4. New Zealand Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Sales Channel
14.6.4.4.1. Direct
14.6.4.4.2. Indirect
14.6.5. Australia
14.6.5.1. Australia Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Animal Type
14.6.5.1.1. Dogs Â
14.6.5.1.2. Cats
14.6.5.1.3. Others
14.6.5.2. Australia Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Policy Type
14.6.5.2.1. Accident only pet insurance
14.6.5.2.2. Time limited pet insurance
14.6.5.2.3. Maximum benefit pet insurance
14.6.5.2.4. Lifetime pet insurance
14.6.5.3. Australia Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Coverage
14.6.5.3.1. Illnesses
14.6.5.3.2. Accidents
14.6.5.3.3. Hereditary Conditions
14.6.5.3.4. Congenital Conditions
14.6.5.3.5. Chronic Conditions
14.6.5.3.6. Cancer
14.6.5.3.7. Diagnostic Treatment
14.6.5.3.8. Â X-Rays, Blood Tests, Ultrasounds
14.6.5.3.9. Surgery
14.6.5.3.10. Hospitalization
14.6.5.3.11. Prescription Medications
14.6.5.3.12. Emergency Care
14.6.5.3.13. Specialty Care
14.6.5.3.14. Alternative Treatment
14.6.5.3.15. Others
14.6.5.4. Australia Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Sales Channel
14.6.5.4.1. Direct
14.6.5.4.2. Indirect
14.6.6. South Korea
14.6.6.1. South Korea Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Animal Type
14.6.6.1.1. Dogs Â
14.6.6.1.2. Cats
14.6.6.1.3. Others
14.6.6.2. South Korea Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Policy Type
14.6.6.2.1. Accident only pet insurance
14.6.6.2.2. Time limited pet insurance
14.6.6.2.3. Maximum benefit pet insurance
14.6.6.2.4. Lifetime pet insurance
14.6.6.3. South Korea Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Coverage
14.6.6.3.1. Illnesses
14.6.6.3.2. Accidents
14.6.6.3.3. Hereditary Conditions
14.6.6.3.4. Congenital Conditions
14.6.6.3.5. Chronic Conditions
14.6.6.3.6. Cancer
14.6.6.3.7. Diagnostic Treatment
14.6.6.3.8. Â X-Rays, Blood Tests, Ultrasounds
14.6.6.3.9. Surgery
14.6.6.3.10. Hospitalization
14.6.6.3.11. Prescription Medications
14.6.6.3.12. Emergency Care
14.6.6.3.13. Specialty Care
14.6.6.3.14. Alternative Treatment
14.6.6.3.15. Others
14.6.6.4. South Korea Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Sales Channel
14.6.6.4.1. Direct
14.6.6.4.2. Indirect
14.6.7. Southeast Asia
14.6.7.1. Southeast Asia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
14.6.7.1.1. Dogs Â
14.6.7.1.2. Cats
14.6.7.1.3. Others
14.6.7.2. Southeast Asia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
14.6.7.2.1. Accident only pet insurance
14.6.7.2.2. Time limited pet insurance
14.6.7.2.3. Maximum benefit pet insurance
14.6.7.2.4. Lifetime pet insurance
14.6.7.3. Southeast Asia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
14.6.7.3.1. Illnesses
14.6.7.3.2. Accidents
14.6.7.3.3. Hereditary Conditions
14.6.7.3.4. Congenital Conditions
14.6.7.3.5. Chronic Conditions
14.6.7.3.6. Cancer
14.6.7.3.7. Diagnostic Treatment
14.6.7.3.8. Â X-Rays, Blood Tests, Ultrasounds
14.6.7.3.9. Surgery
14.6.7.3.10. Hospitalization
14.6.7.3.11. Prescription Medications
14.6.7.3.12. Emergency Care
14.6.7.3.13. Specialty Care
14.6.7.3.14. Alternative Treatment
14.6.7.3.15. Others
14.6.7.4. Southeast Asia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
14.6.7.4.1. Direct
14.6.7.4.2. Indirect
14.6.7.5. Southeast Asia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1. Rest of Asia Pacific Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Animal Type
14.6.8.1.1. Dogs Â
14.6.8.1.2. Cats
14.6.8.1.3. Others
14.6.8.2. Rest of Asia Pacific Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Policy Type
14.6.8.2.1. Accident only pet insurance
14.6.8.2.2. Time limited pet insurance
14.6.8.2.3. Maximum benefit pet insurance
14.6.8.2.4. Lifetime pet insurance
14.6.8.3. Rest of Asia Pacific Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Coverage
14.6.8.3.1. Illnesses
14.6.8.3.2. Accidents
14.6.8.3.3. Hereditary Conditions
14.6.8.3.4. Congenital Conditions
14.6.8.3.5. Chronic Conditions
14.6.8.3.6. Cancer
14.6.8.3.7. Diagnostic Treatment
14.6.8.3.8. Â X-Rays, Blood Tests, Ultrasounds
14.6.8.3.9. Surgery
14.6.8.3.10. Hospitalization
14.6.8.3.11. Prescription Medications
14.6.8.3.12. Emergency Care
14.6.8.3.13. Specialty Care
14.6.8.3.14. Alternative Treatment
14.6.8.3.15. Others
14.6.8.4. Rest of Asia Pacific Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
14.6.8.4.1. Direct
14.6.8.4.2. Indirect
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Animal Type
14.7.3. By Policy Type
14.7.4. By Coverage
14.7.5. By Sales Channel
15. Middle East and Africa Pet Insurance Market
Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle East and Africa Pet Insurance Market
Revenue (US$ Mn)
15.2. Middle East and Africa Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Animal Type
15.2.1. Dogs Â
15.2.2. Cats
15.2.3. Others
15.3. Middle East and Africa Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Policy Type
15.3.1. Accident only pet insurance
15.3.2. Time limited pet insurance
15.3.3. Maximum benefit pet insurance
15.3.4. Lifetime pet insurance
15.4. Middle East and Africa Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Coverage
15.4.1. Illnesses
15.4.2. Accidents
15.4.3. Hereditary Conditions
15.4.4. Congenital Conditions
15.4.5. Chronic Conditions
15.4.6. Cancer
15.4.7. Diagnostic Treatment
15.4.8. Â X-Rays, Blood Tests, Ultrasounds
15.4.9. Surgery
15.4.10. Hospitalization
15.4.11. Prescription Medications
15.4.12. Emergency Care
15.4.13. Specialty Care
15.4.14. Alternative Treatment
15.4.15. Others
15.5. Middle East and Africa Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
15.5.1. Direct
15.5.2. Indirect
15.6. Middle East and Africa Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
15.6.1.1.1. Dogs Â
15.6.1.1.2. Cats
15.6.1.1.3. Others
15.6.1.2. Saudi Arabia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
15.6.1.2.1. Accident only pet insurance
15.6.1.2.2. Time limited pet insurance
15.6.1.2.3. Maximum benefit pet insurance
15.6.1.2.4. Lifetime pet insurance
15.6.1.3. Saudi Arabia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
15.6.1.3.1. Illnesses
15.6.1.3.2. Accidents
15.6.1.3.3. Hereditary Conditions
15.6.1.3.4. Congenital Conditions
15.6.1.3.5. Chronic Conditions
15.6.1.3.6. Cancer
15.6.1.3.7. Diagnostic Treatment
15.6.1.3.8. Â X-Rays, Blood Tests, Ultrasounds
15.6.1.3.9. Surgery
15.6.1.3.10. Hospitalization
15.6.1.3.11. Prescription Medications
15.6.1.3.12. Emergency Care
15.6.1.3.13. Specialty Care
15.6.1.3.14. Alternative Treatment
15.6.1.3.15. Others
15.6.1.4. Saudi Arabia Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
15.6.1.4.1. Direct
15.6.1.4.2. Indirect
15.6.2. UAE
15.6.2.1. UAE Pet Insurance Market Revenue (US$ Mn) and
Forecasts, By Animal Type
15.6.2.1.1. Dogs Â
15.6.2.1.2. Cats
15.6.2.1.3. Others
15.6.2.2. UAE Pet Insurance Market Revenue (US$ Mn) and
Forecasts, By Policy Type
15.6.2.2.1. Accident only pet insurance
15.6.2.2.2. Time limited pet insurance
15.6.2.2.3. Maximum benefit pet insurance
15.6.2.2.4. Lifetime pet insurance
15.6.2.3. UAE Pet Insurance Market Revenue (US$ Mn) and
Forecasts, By Coverage
15.6.2.3.1. Illnesses
15.6.2.3.2. Accidents
15.6.2.3.3. Hereditary Conditions
15.6.2.3.4. Congenital Conditions
15.6.2.3.5. Chronic Conditions
15.6.2.3.6. Cancer
15.6.2.3.7. Diagnostic Treatment
15.6.2.3.8. Â X-Rays, Blood Tests, Ultrasounds
15.6.2.3.9. Surgery
15.6.2.3.10. Hospitalization
15.6.2.3.11. Prescription Medications
15.6.2.3.12. Emergency Care
15.6.2.3.13. Specialty Care
15.6.2.3.14. Alternative Treatment
15.6.2.3.15. Others
15.6.2.4. UAE Pet Insurance Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
15.6.2.4.1. Direct
15.6.2.4.2. Indirect
15.6.3. Egypt
15.6.3.1. Egypt Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
15.6.3.1.1. Dogs Â
15.6.3.1.2. Cats
15.6.3.1.3. Others
15.6.3.2. Egypt Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
15.6.3.2.1. Accident only pet insurance
15.6.3.2.2. Time limited pet insurance
15.6.3.2.3. Maximum benefit pet insurance
15.6.3.2.4. Lifetime pet insurance
15.6.3.3. Egypt Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
15.6.3.3.1. Illnesses
15.6.3.3.2. Accidents
15.6.3.3.3. Hereditary Conditions
15.6.3.3.4. Congenital Conditions
15.6.3.3.5. Chronic Conditions
15.6.3.3.6. Cancer
15.6.3.3.7. Diagnostic Treatment
15.6.3.3.8. Â X-Rays, Blood Tests, Ultrasounds
15.6.3.3.9. Surgery
15.6.3.3.10. Hospitalization
15.6.3.3.11. Prescription Medications
15.6.3.3.12. Emergency Care
15.6.3.3.13. Specialty Care
15.6.3.3.14. Alternative Treatment
15.6.3.3.15. Others
15.6.3.4. Egypt Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
15.6.3.4.1. Direct
15.6.3.4.2. Indirect
15.6.4. Kuwait
15.6.4.1. Kuwait Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
15.6.4.1.1. Dogs Â
15.6.4.1.2. Cats
15.6.4.1.3. Others
15.6.4.2. Kuwait Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
15.6.4.2.1. Accident only pet insurance
15.6.4.2.2. Time limited pet insurance
15.6.4.2.3. Maximum benefit pet insurance
15.6.4.2.4. Lifetime pet insurance
15.6.4.3. Kuwait Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
15.6.4.3.1. Illnesses
15.6.4.3.2. Accidents
15.6.4.3.3. Hereditary Conditions
15.6.4.3.4. Congenital Conditions
15.6.4.3.5. Chronic Conditions
15.6.4.3.6. Cancer
15.6.4.3.7. Diagnostic Treatment
15.6.4.3.8. Â X-Rays, Blood Tests, Ultrasounds
15.6.4.3.9. Surgery
15.6.4.3.10. Hospitalization
15.6.4.3.11. Prescription Medications
15.6.4.3.12. Emergency Care
15.6.4.3.13. Specialty Care
15.6.4.3.14. Alternative Treatment
15.6.4.3.15. Others
15.6.4.4. Kuwait Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
15.6.4.4.1. Direct
15.6.4.4.2. Indirect
15.6.5. South Africa
15.6.5.1. South Africa Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
15.6.5.1.1. Dogs Â
15.6.5.1.2. Cats
15.6.5.1.3. Others
15.6.5.2. South Africa Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
15.6.5.2.1. Accident only pet insurance
15.6.5.2.2. Time limited pet insurance
15.6.5.2.3. Maximum benefit pet insurance
15.6.5.2.4. Lifetime pet insurance
15.6.5.3. South Africa Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
15.6.5.3.1. Illnesses
15.6.5.3.2. Accidents
15.6.5.3.3. Hereditary Conditions
15.6.5.3.4. Congenital Conditions
15.6.5.3.5. Chronic Conditions
15.6.5.3.6. Cancer
15.6.5.3.7. Diagnostic Treatment
15.6.5.3.8. Â X-Rays, Blood Tests, Ultrasounds
15.6.5.3.9. Surgery
15.6.5.3.10. Hospitalization
15.6.5.3.11. Prescription Medications
15.6.5.3.12. Emergency Care
15.6.5.3.13. Specialty Care
15.6.5.3.14. Alternative Treatment
15.6.5.3.15. Others
15.6.5.4. South Africa Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
15.6.5.4.1. Direct
15.6.5.4.2. Indirect
15.6.6. Rest of Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Pet
Insurance Market Revenue (US$ Mn) and Forecasts, By Animal Type
15.6.6.1.1. Dogs Â
15.6.6.1.2. Cats
15.6.6.1.3. Others
15.6.6.2. Rest of Middle East & Africa Pet
Insurance Market Revenue (US$ Mn) and Forecasts, By Policy Type
15.6.6.2.1. Accident only pet insurance
15.6.6.2.2. Time limited pet insurance
15.6.6.2.3. Maximum benefit pet insurance
15.6.6.2.4. Lifetime pet insurance
15.6.6.3. Rest of Middle East & Africa Pet
Insurance Market Revenue (US$ Mn) and Forecasts, By Coverage
15.6.6.3.1. Illnesses
15.6.6.3.2. Accidents
15.6.6.3.3. Hereditary Conditions
15.6.6.3.4. Congenital Conditions
15.6.6.3.5. Chronic Conditions
15.6.6.3.6. Cancer
15.6.6.3.7. Diagnostic Treatment
15.6.6.3.8. Â X-Rays, Blood Tests, Ultrasounds
15.6.6.3.9. Surgery
15.6.6.3.10. Hospitalization
15.6.6.3.11. Prescription Medications
15.6.6.3.12. Emergency Care
15.6.6.3.13. Specialty Care
15.6.6.3.14. Alternative Treatment
15.6.6.3.15. Others
15.6.6.4. Rest of Middle East & Africa Pet
Insurance Market Revenue (US$ Mn) and Forecasts, By Sales Channel
15.6.6.4.1. Direct
15.6.6.4.2. Indirect
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Animal Type
15.7.3. By Policy Type
15.7.4. By Coverage
15.7.5. By Sales Channel
16. Latin America Pet Insurance Market Analysis
and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin America Pet Insurance Market Revenue
(US$ Mn)
16.2. Latin America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Animal Type
16.2.1. Dogs Â
16.2.2. Cats
16.2.3. Others
16.3. Latin America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Policy Type
16.3.1. Accident only pet insurance
16.3.2. Time limited pet insurance
16.3.3. Maximum benefit pet insurance
16.3.4. Lifetime pet insurance
16.4. Latin America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Coverage
16.4.1. Illnesses
16.4.2. Accidents
16.4.3. Hereditary Conditions
16.4.4. Congenital Conditions
16.4.5. Chronic Conditions
16.4.6. Cancer
16.4.7. Diagnostic Treatment
16.4.8. Â X-Rays, Blood Tests, Ultrasounds
16.4.9. Surgery
16.4.10. Hospitalization
16.4.11. Prescription Medications
16.4.12. Emergency Care
16.4.13. Specialty Care
16.4.14. Alternative Treatment
16.4.15. Others
16.5. Latin America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
16.5.1. Direct
16.5.2. Indirect
16.6. Latin America Pet Insurance Market Revenue
(US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Animal Type
16.6.1.1.1. Dogs Â
16.6.1.1.2. Cats
16.6.1.1.3. Others
16.6.1.2. Brazil Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Policy Type
16.6.1.2.1. Accident only pet insurance
16.6.1.2.2. Time limited pet insurance
16.6.1.2.3. Maximum benefit pet insurance
16.6.1.2.4. Lifetime pet insurance
16.6.1.3. Brazil Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Coverage
16.6.1.3.1. Illnesses
16.6.1.3.2. Accidents
16.6.1.3.3. Hereditary Conditions
16.6.1.3.4. Congenital Conditions
16.6.1.3.5. Chronic Conditions
16.6.1.3.6. Cancer
16.6.1.3.7. Diagnostic Treatment
16.6.1.3.8. Â X-Rays, Blood Tests, Ultrasounds
16.6.1.3.9. Surgery
16.6.1.3.10. Hospitalization
16.6.1.3.11. Prescription Medications
16.6.1.3.12. Emergency Care
16.6.1.3.13. Specialty Care
16.6.1.3.14. Alternative Treatment
16.6.1.3.15. Others
16.6.1.4. Brazil Pet Insurance Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
16.6.1.4.1. Direct
16.6.1.4.2. Indirect
16.6.2. Argentina
16.6.2.1. Argentina Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Animal Type
16.6.2.1.1. Dogs Â
16.6.2.1.2. Cats
16.6.2.1.3. Others
16.6.2.2. Argentina Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Policy Type
16.6.2.2.1. Accident only pet insurance
16.6.2.2.2. Time limited pet insurance
16.6.2.2.3. Maximum benefit pet insurance
16.6.2.2.4. Lifetime pet insurance
16.6.2.3. Argentina Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Coverage
16.6.2.3.1. Illnesses
16.6.2.3.2. Accidents
16.6.2.3.3. Hereditary Conditions
16.6.2.3.4. Congenital Conditions
16.6.2.3.5. Chronic Conditions
16.6.2.3.6. Cancer
16.6.2.3.7. Diagnostic Treatment
16.6.2.3.8. Â X-Rays, Blood Tests, Ultrasounds
16.6.2.3.9. Surgery
16.6.2.3.10. Hospitalization
16.6.2.3.11. Prescription Medications
16.6.2.3.12. Emergency Care
16.6.2.3.13. Specialty Care
16.6.2.3.14. Alternative Treatment
16.6.2.3.15. Others
16.6.2.4. Argentina Pet Insurance Market Revenue (US$
Mn) and Forecasts, By Sales Channel
16.6.2.4.1. Direct
16.6.2.4.2. Indirect
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Animal Type
16.6.3.1.1. Dogs Â
16.6.3.1.2. Cats
16.6.3.1.3. Others
16.6.3.2. Rest of Latin America Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Policy Type
16.6.3.2.1. Accident only pet insurance
16.6.3.2.2. Time limited pet insurance
16.6.3.2.3. Maximum benefit pet insurance
16.6.3.2.4. Lifetime pet insurance
16.6.3.3. Rest of Latin America Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Coverage
16.6.3.3.1. Illnesses
16.6.3.3.2. Accidents
16.6.3.3.3. Hereditary Conditions
16.6.3.3.4. Congenital Conditions
16.6.3.3.5. Chronic Conditions
16.6.3.3.6. Cancer
16.6.3.3.7. Diagnostic Treatment
16.6.3.3.8. Â X-Rays, Blood Tests, Ultrasounds
16.6.3.3.9. Surgery
16.6.3.3.10. Hospitalization
16.6.3.3.11. Prescription Medications
16.6.3.3.12. Emergency Care
16.6.3.3.13. Specialty Care
16.6.3.3.14. Alternative Treatment
16.6.3.3.15. Others
16.6.3.4. Rest of Latin America Pet Insurance Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
16.6.3.4.1. Direct
16.6.3.4.2. Indirect
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Animal Type
16.7.3. By Policy Type
16.7.4. By Coverage
16.7.5. By Sales Channel
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2021
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. American Modern Insurance
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Figo Pet Insurance LLC.
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. GEICO
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. Healthy Paws Pet Insurance, LLC.
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. Lemonade Insurance Agency, LLC
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. MetLife Services and Solutions, LLC
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Pet Assure Corp.
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Pets Best Insurance Services, LLC.
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. Tata Capital Financial Services Limited
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. The Travelers Indemnity Company.
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. TK PETCARE SOLUTIONS PRIVATE LIMITED
18.11.1. Company Details
18.11.2. Company Overview
18.11.3. Product Offerings
18.11.4. Key Developments
18.11.5. Financial Analysis
18.11.6. SWOT Analysis
18.11.7. Business Strategies
18.12. Trupanion
18.12.1. Company Details
18.12.2. Company Overview
18.12.3. Product Offerings
18.12.4. Key Developments
18.12.5. Financial Analysis
18.12.6. SWOT Analysis
18.12.7. Business Strategies
18.13. Other Market Participants
19. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.